# CAPRELSA

NDC: 58468-7840
Generic name: Vandetanib
Labeler / Manufacturer: Genzyme Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20110725

FDA application: NDA022405

## Active ingredients

- VANDETANIB: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"58468-7840"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=58468-7840
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e5721cb8-4185-47b9-bbb3-1c587e558a03